Posted in Regulatory Agios mulls early FDA filing for sickle cell therapy April 1, 2026 Pharmaphorum Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months. RegulatoryHematologyRead full story